Search Results - "International clinical psychopharmacology"

Efficacy of treatments for anxiety disorders: a meta-analysis by Bandelow, Borwin, Reitt, Markus, Röver, Christian, Michaelis, Sophie, Görlich, Yvonne, Wedekind, Dirk

“…To our knowledge, no previous meta-analysis has attempted to compare the efficacy of pharmacological, psychological and combined treatments for the three main…”
Get full text

Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders by Fineberg, Naomi A., Hollander, Eric, Pallanti, Stefano, Walitza, Susanne, Grünblatt, Edna, Dell’Osso, Bernardo Maria, Albert, Umberto, Geller, Daniel A., Brakoulias, Vlasios, Janardhan Reddy, Y.C., Arumugham, Shyam Sundar, Shavitt, Roseli G., Drummond, Lynne, Grancini, Benedetta, De Carlo, Vera, Cinosi, Eduardo, Chamberlain, Samuel R., Ioannidis, Konstantinos, Rodriguez, Carolyn I., Garg, Kabir, Castle, David, Van Ameringen, Michael, Stein, Dan J., Carmi, Lior, Zohar, Joseph, Menchon, Jose M.

“…In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to…”
Get full text

The social and economic burden of treatment-resistant schizophrenia: a systematic literature review by Kennedy, James L, Altar, C Anthony, Taylor, Danielle L, Degtiar, Irina, Hornberger, John C

“…Patients with schizophrenia often fail to respond to an initial course of therapy. This study systematically reviewed the societal and economic burden of…”
Get full text

A comparative review of escitalopram, paroxetine, and sertraline: are they all alike? by Sanchez, Connie, Reines, Elin H, Montgomery, Stuart A

“…It is known that newer antidepressants, such as the selective serotonin reuptake inhibitors (SSRIs), provide advantages in tolerability over antidepressants…”
Get full text

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder by Katona, Cornelius, Hansen, Thomas, Olsen, Christina Kurre

“…The efficacy and tolerability of Lu AA21004 at 5 mg/day, a novel multimodal antidepressant, were assessed in elderly patients with recurrent major depressive…”
Get full text

Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder by Boulenger, Jean-Philippe, Loft, Henrik, Olsen, Christina Kurre

“…This study assessed the efficacy, tolerability and safety of vortioxetine versus placebo in adults with recurrent major depressive disorder. This double-blind,…”
Get full text

Antidepressant psychopharmacology: is inflammation a future target? by Benedetti, Francesco, Zanardi, Raffaella, Mazza, Mario Gennaro

“…Raised inflammatory setpoints have been associated with major depression and its detrimental consequences on brain function, as they lead to increased…”
Get full text

OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females by Brin, Mitchell F., Durgam, Suresh, Lum, Arlene, James, Lynn, Liu, Jeen, Thase, Michael E., Szegedi, Armin

“…This 24-week double-blind placebo-controlled multicenter randomized phase 2 trial evaluated efficacy and safety of onabotulinumtoxinA (onabotA; BOTOX) vs…”
Get full text

Clinical specificity profile for novel rapid acting antidepressant drugs by Scala, Mauro, Fanelli, Giuseppe, De Ronchi, Diana, Serretti, Alessandro, Fabbri, Chiara

“…Mood disorders are recurrent/chronic diseases with variable clinical remission rates. Available antidepressants are not effective in all patients and often…”
Get full text

Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology by Castle, David, Beilharz, Francesca, Phillips, Katharine A., Brakoulias, Vlasios, Drummond, Lynne M., Hollander, Eric, Ioannidis, Konstantinos, Pallanti, Stefano, Chamberlain, Samuel R., Rossell, Susan L., Veale, David, Wilhelm, Sabine, Van Ameringen, Michael, Dell’Osso, Bernardo, Menchon, Jose M., Fineberg, Naomi A.

“…Body dysmorphic disorder (BDD) is characterized by a preoccupation with a perceived appearance flaw or flaws that are not observable to others. BDD is…”
Get full text

Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab? by Ferrucci, Silvia Mariel, Tavecchio, Simona, Nicolini, Gregorio, Angileri, Luisa, Ceresa, Alessandro, Del Tordello, Giulia, Berti, Emilio, Marzano, Angelo Valerio, Buoli, Massimiliano

“…Atopic dermatitis (AD) is an inflammatory skin disease. Patients with AD are prone to develop anxiety and mood disorders. Aim of this study is to investigate…”
Get full text

Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology by Lim, Bryant, Sproule, Beth A., Zahra, Zarin, Sunderji, Nadiya, Kennedy, Sidney H., Rizvi, Sakina J.

“…Benzodiazepines are frequently prescribed on an ongoing basis to individuals with depression, mainly to alleviate anxiety or insomnia, despite current…”
Get full text

Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors by Merolla, Aurora, De Lorenzo, Rebecca, Paolazzi, Giacomo, Critelli, Sara, Palladini, Mariagrazia, Damanti, Sarah, Vitali, Giordano, Canti, Valentina, Cilla, Marta, Martinenghi, Sabina, Falbo, Elisabetta, Ferrante, Marica, Castellani, Jacopo, Pacioni, Giacomo, Magnaghi, Cristiano, Fumagalli, Anna, Mazza, Mario G, Benedetti, Francesco, Rovere-Querini, Patrizia

“…Coronavirus disease 2019 (COVID-19) may lead to neuropsychiatric sequelae. Palmitoylethanolamide (PEA) is an anti-inflammatory and neuroprotective amide used…”
Get full text

l -carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial by Nasiri, Mehry, Parmoon, Zohal, Farahmand, Yalda, Moradi, Ali, Farahmand, Kimia, Moradi, Kamyar, Basti, Fatemeh A, Mohammadi, Mohammad-Reza, Akhondzadeh, Shahin

“…The present study was designed to evaluate the efficacy and safety of l-carnitine as an adjuvant agent to risperidone in the treatment of autism spectrum…”
Get full text

The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results by Elefante, Camilla, Brancati, Giulio Emilio, Pistolesi, Gabriele, Amadori, Salvatore, Torrigiani, Samuele, Baldacci, Filippo, Ceravolo, Roberto, Ismail, Zahinoor, Lattanzi, Lorenzo, Perugi, Giulio

“…Our study aimed to examine how the presence of Mild Behavioral Impairment (MBI) symptoms influenced the outcome of late-life depression (LLD). Twenty-nine…”
Get full text

Persistent suicidal ideation in major depressive disorder patients: still in need of empathic understanding by Pompili, Maurizio

Get full text

The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students by Nahidi, Mahsa, Ahmadi, Motahareh, Fayyazi Bordbar, Mohammad Reza, Morovatdar, Negar, Khadem-Rezayian, Majid, Abdolalizadeh, Adeleh

“…This study investigates the prevalence of mobile phone addiction among medical students and its relationship with depression, anxiety, and sleep quality. The…”
Get full text

Efficacy and safety of agomelatine versus SSRIs/SNRIs for post-stroke depression: a systematic review and meta-analysis of randomized controlled trials by Chen, Yicong, Li, Jianle, Liao, Mengshi, He, Yinxin, Dang, Chao, Yu, Jian, Xing, Shihui, Zeng, Jinsheng

“…Agomelatine is effective in the treatment of depression, but its effect for post-stroke depression (PSD) remains unclear. This study was conducted to compare…”
Get full text

Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge by Andreu, Helena, Serra-Sarró, Blanca, Bueno, Laura, de Juan, Òscar, Ochandiano, Iñaki, Olivier, Luis, Álvarez, Helena, Herrero, Ailin, Mantellini, Cecilia, Vicente, Miguel, Sagué-Vilavella, Maria, Ilzarbe, Lidia, Pintor, Luis, Garriga, Marina, Llorca-Bofí, Vicent, Bioque, Miquel

“…Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by a wide variety of symptoms, including frequent neurological and psychiatric…”
Get full text

The impact of efficacy of long-acting injectable antipsychotics on caregivers' burden of patients with schizophrenia by Capuzzi, Enrico, Quitadamo, Cecilia, Caldiroli, Alice, Clerici, Massimo, Buoli, Massimiliano

Get full text